MYRIAD GENETICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $352.9M | $1.32B | $257.4M |
| FY2022 | $312.9M | $1.20B | $56.9M |
| FY2023 | $363.3M | $1.15B | $132.1M |
| FY2024 | $326.5M | $1.03B | $102.4M |
| FY2025 | $338.6M | $706.6M | $149.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $352.9M | $1.32B | $257.4M |
| FY2022 | $312.9M | $1.20B | $56.9M |
| FY2023 | $363.3M | $1.15B | $132.1M |
| FY2024 | $326.5M | $1.03B | $102.4M |
| FY2025 | $338.6M | $706.6M | $149.6M |